Literature DB >> 21172885

Gemtuzumab ozogamicin: one size does not fit all--the case for personalized therapy.

Farhad Ravandi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21172885     DOI： 10.1200/JCO.2010.32.2693

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

Review 1.  Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.

Authors:  Satish K Singh; Donna L Luisi; Roger H Pak
Journal:  Pharm Res       Date:  2015-05-19       Impact factor: 4.200

Review 2.  Frontline treatment of acute myeloid leukemia in adults.

Authors:  Gevorg Tamamyan; Tapan Kadia; Farhad Ravandi; Gautam Borthakur; Jorge Cortes; Elias Jabbour; Naval Daver; Maro Ohanian; Hagop Kantarjian; Marina Konopleva
Journal:  Crit Rev Oncol Hematol       Date:  2016-12-11       Impact factor: 6.312

3.  The impact of trisulfide modification of antibodies on the properties of antibody-drug conjugates manufactured using thiol chemistry.

Authors:  Renpeng Liu; Xuan Chen; Junia Dushime; Megan Bogalhas; Alexandru C Lazar; Thomas Ryll; Lintao Wang
Journal:  MAbs       Date:  2017-01-31       Impact factor: 5.857

4.  The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma.

Authors:  Peter D Senter; Eric L Sievers
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908

Review 5.  Drug-conjugated antibodies for the treatment of cancer.

Authors:  John M Lambert
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

Review 6.  Ocular Adverse Events Associated with Antibody-Drug Conjugates in Human Clinical Trials.

Authors:  Joshua Seth Eaton; Paul E Miller; Mark J Mannis; Christopher J Murphy
Journal:  J Ocul Pharmacol Ther       Date:  2015-11-05       Impact factor: 2.671

Review 7.  Enediynes: Exploration of microbial genomics to discover new anticancer drug leads.

Authors:  Ben Shen; Xiaohui Yan; Tingting Huang; Huiming Ge; Dong Yang; Qihui Teng; Jeffrey D Rudolf; Jeremy R Lohman
Journal:  Bioorg Med Chem Lett       Date:  2014-11-14       Impact factor: 2.823

Review 8.  Site-specific antibody drug conjugates for cancer therapy.

Authors:  Siler Panowski; Sunil Bhakta; Helga Raab; Paul Polakis; Jagath R Junutula
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.